Strengths and limitations of β2 agonists in the treatment of oedema during ALI

F. Grimbert (La Tronche, France)

Source: Annual Congress 2005 - An update on the mechanisms of pulmonary oedema formation and reabsorption

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Grimbert (La Tronche, France). Strengths and limitations of β2 agonists in the treatment of oedema during ALI. Annual Congress 2005 - An update on the mechanisms of pulmonary oedema formation and reabsorption

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A novel approach for optimal lung recruitment in acute lung injury
Source: Annual Congress 2005 - Pulmonary function outcome, respiratory morbidity in prematurely born children and acute lung injury
Year: 2005


Mechanisms of acute lung injury
Source: Annual Congress 2005 - In vivo - approaches to lung injury
Year: 2005

Acute lung injury as a possible adverse drug reaction related to gefitinib
Source: Eur Respir J 2002 Jan 01;22(1):179-181
Year: 2003



Ventilator-associated lung injury: a search for better therapeutic targets
Source: Eur Respir J 2007; 30: 1216-1226
Year: 2007



Resolution of acute lung injury and inflammation: a translational mouse model
Source: Eur Respir J 2012; 39: 1162-1170
Year: 2012



Ventilator-induced lung injury
Source: Eur Respir J 2003; 22: 2S-9S
Year: 2003



Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury},
Source: Eur Respir J 2012; 40: 939-948
Year: 2012



Drug-induced ILD
Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders
Year: 2007


Salmeterol prevents pneumonia and reduces biomarkers of inflammation/epithelial damage but not acute lung injury following oesophagectomy-the results of BALTI-prevention trial
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013

Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury
Source: Eur Respir J 2009; 33: 634-645
Year: 2009



Cardiopulmonary effects of iloprost in experimental acute lung injury
Source: Eur Respir J 2005; 25: 81-87
Year: 2005



Unilateral treatment with lung volume reduction coils in patients with severe emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013

Mechanical ventilation interacts with experimental low dose endotoxemia to induce apoptotic lung responses in mice
Source: Annual Congress 2005 - In vivo - approaches to lung injury
Year: 2005


Salutary effect of fructose-1,6-diphosphate in lung injury: a randomized double-blinded placebo clinical trial
Source: Annual Congress 2007 - Lung recruitment
Year: 2007


The use of surfactant in severe reperfusion injury after lung transplantation
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005


Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery
Source: Eur Respir J 2006; 27: 1026-1032
Year: 2006



Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment
Source: Eur Respir J 2012; 40: 416-423
Year: 2012



Elastase-induced emphysema: Species differences in markers of acute lung injury relate to the magnitude of emphysema development
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010

Increased injury and intramuscular collagen of the diaphragm in COPD: autopsy observations
Source: Eur Respir J 2006; 27: 51-59
Year: 2006